EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA vaccine targets Epstein-Barr virus in early human trial
⭐️ VACCINE ⭐️ OngoingThis early-stage study is testing an experimental mRNA vaccine called mRNA-1195 to see if it is safe and can protect against Epstein-Barr virus (EBV). About 482 healthy adults aged 18 to 55 will receive either the vaccine or a placebo. The study will monitor side effects and meas…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:53 UTC
-
Could this mRNA vaccine stop the virus behind mono and cancer?
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental mRNA vaccine called mRNA-1189 to see if it can safely prevent Epstein-Barr virus (EBV) infection. About 867 healthy adolescents and adults aged 10 to 30 will receive either the vaccine or a placebo. The main goal is to check for side effects and m…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:56 UTC
-
Blood test guides chemo choice for throat cancer patients
Disease control OngoingThis study tests whether a blood test for Epstein-Barr virus (EBV) DNA can help doctors choose the best chemotherapy for people with advanced nasopharyngeal cancer. After standard radiation and chemo, patients with no detectable EBV DNA are randomly assigned to either more chemo …
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC